"Kingfisher TMS is a leading provider of Transcranial Magnetic Stimulation (TMS), a non-pharmacological, non-invasive FDA-approved therapy for treatment-resistent depression. TMS is covered by most insurance companies."

During the past decade, Kingfisher Cooperative, LLC conducted 10 clinical trials. In the 10-year time frame, 10 clinical trials started and 2 clinical trials were completed, i.e. on average, 20% percent of trials that started reached the finish line to date. In the past 5 years, 6 clinical trials started and 1 clinical trials were completed. i.e. 16.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Kingfisher Cooperative, LLC" #1 sponsor was "Biogen" with 4 trials, followed by "Allergan" with 1 trials sponsored, "AriBio Co., Ltd." with 1 trials sponsored, "Eisai Inc." with 1 trials sponsored and "Eli Lilly and Company" with 1 trials sponsored. Other sponsors include -3 different institutions and companies that sponsored additional 7 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Kingfisher Cooperative, LLC" #1 collaborator was "Alzheimer's Therapeutic Research Institute" with 1 trials as a collaborator, "Biogen" with 1 trials as a collaborator, "National Institute on Aging (NIA)" with 1 trials as a collaborator and "Vanderbilt University" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.

According to Clinical.Site data, the most researched conditions in "Kingfisher Cooperative, LLC" are "Alzheimer's Disease" (3 trials), "Alzheimer Disease" (2 trials), "Alzheimer's Disease Dementia" (1 trials), "Cognitive Dysfunction" (1 trials) and "Early Alzheimer's Disease" (1 trials). Many other conditions were trialed in "Kingfisher Cooperative, LLC" in a lesser frequency.

Most popular intervention types in "Kingfisher Cooperative, LLC" are "Drug" (10 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (6 trials), "Aducanumab" (3 trials), "AR1001" (1 trials), "Atogepant" (1 trials) and "BIIB080" (1 trials). Other intervention names were less common.

The vast majority of trials in "Kingfisher Cooperative, LLC" are 10 trials for "All" genders.

Currently, there are NaN active trials in "Kingfisher Cooperative, LLC". undefined are not yet recruiting, 3 are recruiting, 4 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Kingfisher Cooperative, LLC, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Kingfisher Cooperative, LLC, 0 "Phase 1" clinical trials were conducted, 5 "Phase 2" clinical trials and 6 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".